Kineta's Grant - V Round

Kineta raised a round of funding on March 30, 2010. Investors include National Institute of Allergy and Infectious Diseases.

Kineta is a nationally-recognized biotechnology company focused on developing leading edge therapeutics in three large high need therapeutic areas: autoimmune disease, viral disease and chronic pain. …

Articles about Kineta's Grant - V Round: